Last update 06 Jun 2026

SNH-118110

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
SNH-118110
Target
RET
Action
modulators
Mechanism
RET modulators(Tyrosine-protein kinase receptor RET modulators)
Therapeutic Areas
Neoplasms
Active Indication
Advanced Malignant Solid NeoplasmRET mutation Solid Tumors
Inactive Indication-
Originator Organization
ScinnoHub Pharmaceutical Co., Ltd.ScinnoHub Pharmaceutical Co., Ltd.
Active Organization
ScinnoHub Pharmaceutical Co., Ltd.ScinnoHub Pharmaceutical Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with SNH-118110
CTR20262161
/ Not yet recruitingPhase 1
SNH-118110在晚期实体瘤患者中的安全性、耐受性、药代动力学和有效性的I期临床研究
[Translation] A Phase I clinical study of the safety, tolerability, pharmacokinetics, and efficacy of SNH-118110 in patients with advanced solid tumors.
100 Clinical Results associated with SNH-118110
Login to view more data
100 Translational Medicine associated with SNH-118110
Login to view more data
100 Patents (Medical) associated with SNH-118110
Login to view more data
100 Deals associated with SNH-118110
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
China
ScinnoHub Pharmaceutical Co., Ltd.ScinnoHub Pharmaceutical Co., Ltd.
03 Jun 2026
RET mutation Solid TumorsIND Approval
China
ScinnoHub Pharmaceutical Co., Ltd.ScinnoHub Pharmaceutical Co., Ltd.
27 May 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free